MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer

Summary

This clinical trial tests the feasibility of using the MyCap mobile application (app) for tracking time burden from treatment for patients with pancreatic cancer. Pancreatic cancer is best treated with many care teams, such as medical oncology and surgery, requiring patients to dedicate significant time coordinating appointments among different doctors. This time commitment is referred to as time toxicity, defined as the time spent undergoing cancer-related medical care, such as emergency visits, ambulatory care, lab and infusion visits, hospitalizations, and the commuting and waiting times associated with each. At present, time toxicity is still understudied within the medical literature, with no gold standard established for the method of measurement. The MyCap mobile app may be a feasible way to track the time burden from treatment for patients with pancreatic cancer.

Eligibility

Inclusion Criteria:

* Adults ≥ 18 years old
* Diagnosed with pancreatic adenocarcinoma undergoing active treatment or planning to start active treatment within the next 30 days
* English speaking
* Access to a smartphone (Android or iOS)

Exclusion Criteria:

* Prisoners
* Patients undergoing cancer surveillance

Conditions2

Locations1 site

Find trials near these locations

Browse More Trials